Annual Total Expenses
$1.62 B
+$451.44 M+38.66%
31 December 2023
Summary:
Genmab A/S annual total expenses is currently $1.62 billion, with the most recent change of +$451.44 million (+38.66%) on 31 December 2023. During the last 3 years, it has risen by +$749.83 million (+86.24%). GMAB annual total expenses is now at all-time high.GMAB Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$504.16 M
-$13.46 M-2.60%
01 September 2024
Summary:
Genmab A/S quarterly total expenses is currently $504.16 million, with the most recent change of -$13.46 million (-2.60%) on 01 September 2024. Over the past year, it has increased by +$70.04 million (+16.13%). GMAB quarterly total expenses is now -2.60% below its all-time high of $517.62 million, reached on 30 June 2024.GMAB Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GMAB Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +16.1% |
| 3 y3 years | +86.2% | +81.1% |
| 5 y5 years | +295.9% | +333.2% |
GMAB Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +86.2% | -2.6% | +108.2% |
| 5 y | 5 years | at high | +295.9% | -2.6% | +333.2% |
| alltime | all time | at high | +2314.6% | -2.6% | +5131.0% |
Genmab A/S Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $504.16 M(-2.6%) |
| June 2024 | - | $517.62 M(+6.3%) |
| Mar 2024 | - | $486.79 M(+12.1%) |
| Dec 2023 | $1.62 B(+38.7%) | $434.12 M(-1.8%) |
| Sept 2023 | - | $442.04 M(+12.0%) |
| June 2023 | - | $394.76 M(+13.3%) |
| Mar 2023 | - | $348.56 M(-1.0%) |
| Dec 2022 | $1.17 B(+34.3%) | $352.20 M(+20.7%) |
| Sept 2022 | - | $291.89 M(+6.5%) |
| June 2022 | - | $274.15 M(+13.2%) |
| Mar 2022 | - | $242.12 M(-13.0%) |
| Dec 2021 | $869.44 M(+49.4%) | $278.40 M(+23.7%) |
| Sept 2021 | - | $225.13 M(+17.2%) |
| June 2021 | - | $192.04 M(+12.9%) |
| Mar 2021 | - | $170.05 M(-8.2%) |
| Dec 2020 | $581.93 M(+42.3%) | $185.34 M(+36.2%) |
| Sept 2020 | - | $136.04 M(-3.4%) |
| June 2020 | - | $140.89 M(+16.2%) |
| Mar 2020 | - | $121.20 M(+4.2%) |
| Dec 2019 | $409.05 M(+57.0%) | $116.37 M(+13.4%) |
| Sept 2019 | - | $102.64 M(+7.1%) |
| June 2019 | - | $95.83 M(+2.1%) |
| Mar 2019 | - | $93.90 M(+19.3%) |
| Dec 2018 | $260.58 M(+67.7%) | $78.73 M(+26.7%) |
| Sept 2018 | - | $62.13 M(+3.5%) |
| June 2018 | - | $60.03 M(+1.9%) |
| Mar 2018 | - | $58.89 M(+18.4%) |
| Dec 2017 | $155.41 M(+37.0%) | $49.72 M(+18.7%) |
| Sept 2017 | - | $41.90 M(+19.6%) |
| June 2017 | - | $35.03 M(+19.5%) |
| Mar 2017 | - | $29.33 M(-7.9%) |
| Dec 2016 | $113.45 M(+89.4%) | $31.84 M(+19.4%) |
| Sept 2016 | - | $26.66 M(-17.2%) |
| June 2016 | - | $32.19 M(+41.5%) |
| Mar 2016 | - | $22.74 M(-22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $59.91 M(-42.6%) | $29.23 M(+45.3%) |
| Sept 2015 | - | $20.12 M(+1.1%) |
| June 2015 | - | $19.90 M(-298.6%) |
| Mar 2015 | - | -$10.02 M(-138.6%) |
| Dec 2014 | $104.38 M(-1.4%) | $25.94 M(+10.4%) |
| Sept 2014 | - | $23.51 M(-13.4%) |
| June 2014 | - | $27.14 M(-1.9%) |
| Mar 2014 | - | $27.67 M(-6.8%) |
| Dec 2013 | $105.82 M(+1.9%) | $29.69 M(+15.3%) |
| Sept 2013 | - | $25.76 M(-5.7%) |
| June 2013 | - | $27.32 M(+18.1%) |
| Mar 2013 | - | $23.12 M(-22.2%) |
| Dec 2012 | $103.84 M(-7.4%) | $29.73 M(+23.7%) |
| Sept 2012 | - | $24.03 M(-6.6%) |
| June 2012 | - | $25.73 M(+5.6%) |
| Mar 2012 | - | $24.36 M(-14.5%) |
| Dec 2011 | $112.15 M(-15.2%) | $28.50 M(+1.0%) |
| Sept 2011 | - | $28.22 M(-2.1%) |
| June 2011 | - | $28.82 M(+8.4%) |
| Mar 2011 | - | $26.58 M(-18.2%) |
| Dec 2010 | $132.23 M(-34.8%) | $32.50 M(+293.4%) |
| Sept 2010 | - | $8.26 M(-81.7%) |
| June 2010 | - | $45.03 M(-4.3%) |
| Mar 2010 | - | $47.05 M(-28.1%) |
| Dec 2009 | $202.89 M(-27.2%) | $65.42 M(+56.8%) |
| Sept 2009 | - | $41.74 M(-8.9%) |
| June 2009 | - | $45.84 M(-8.7%) |
| Mar 2009 | - | $50.23 M |
| Dec 2008 | $278.61 M(+75.9%) | - |
| Dec 2007 | $158.43 M(+54.8%) | - |
| Dec 2006 | $102.36 M(+16.4%) | - |
| Dec 2005 | $87.93 M(-220.3%) | - |
| Dec 2004 | -$73.12 M(+75.4%) | - |
| Dec 2003 | -$41.69 M(-174.4%) | - |
| Dec 2002 | $56.01 M | - |
FAQ
- What is Genmab A/S annual total expenses?
- What is the all time high annual total expenses for Genmab A/S?
- What is Genmab A/S quarterly total expenses?
- What is the all time high quarterly total expenses for Genmab A/S?
- What is Genmab A/S quarterly total expenses year-on-year change?
What is Genmab A/S annual total expenses?
The current annual total expenses of GMAB is $1.62 B
What is the all time high annual total expenses for Genmab A/S?
Genmab A/S all-time high annual total expenses is $1.62 B
What is Genmab A/S quarterly total expenses?
The current quarterly total expenses of GMAB is $504.16 M
What is the all time high quarterly total expenses for Genmab A/S?
Genmab A/S all-time high quarterly total expenses is $517.62 M
What is Genmab A/S quarterly total expenses year-on-year change?
Over the past year, GMAB quarterly total expenses has changed by +$70.04 M (+16.13%)